Work-related musculoskeletal disorders: A survey of physical therapists in Izmir-Turkey

BMC Musculoskeletal Disorders

Volumn 5, Issue , 2004, Pages

  Salik, Yesim ^a   Özcan, Ayse ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; FEMALE; HAND INJURY; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; MALE; MUSCULOSKELETAL DISEASE; NECK INJURY; OCCUPATIONAL ACCIDENT; PHYSICIAN; PHYSIOTHERAPIST; PREVALENCE; REVIEW; RISK FACTOR; SHOULDER INJURY; TASK PERFORMANCE; TURKEY (BIRD); WRIST INJURY;

ACCIDENTS, OCCUPATIONAL; ADULT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; PHYSICAL THERAPY SPECIALTY; QUESTIONNAIRES; TURKEY; WORK; WOUNDS AND INJURIES;

EID: 13444309410     PISSN: 14712474     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-5-27     Document Type: Review

References (51)

1. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ: Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998, 316:333-338.
2. Begg C, Cho M, Eastwood S, Norton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF: Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996, 276:637-639.
3. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998, 352:609-613.
4. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ: Sire is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998, 78:209-216.
5. Li Wan Po A: PJ Practice Checklist: Topical Analgesics. The Pharmaceutical Journal 1996 [http://www.pharmj.com/Index.html].
6. British National Formulary No 45 London: British Medical Association, Royal Pharmaceutical Society; 2003.
7. Martindale: the extra pharmacopoeia 32nd edition. Edited by: Reynolds JEF. London: Royal Pharmaceutical Society; 1999.
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996, 17:1-12.
9. Smith LA, Oldman AD, McQuay HJ, Moore RA: Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain. Pain 2000, 86:119-132.
10. Cook RJ, Sackett DL: The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995, 310:452-454.
11. Morris JA, Gardner MJ: Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In Statistics with confidence - confidence intervals and statistical guidelines Edited by: Gardner MJ, Altman DG. London: British Medical Journal; 1995:50-63.
12. L'Abbe KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med 1987, 107:224-233.
13. Gavaghan DJ, Moore RA, McQuay HJ: An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data. Pain 2000, 85:415-424.
14. Higgins J, Thompson S, Deeks J, Altman D: Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002, 7:51-61.
15. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ: Impact of covert duplicate publication on meta-analysis: a case study. BMJ 1997, 315:635-640.
16. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999, 354:1896-1900.
17. Bolten W: Felbinac-Gel zur Behandlung lokalisierter extraartikulärer rheumatischer Beschwerden - eine multizentrische, placebokontrollierte, randomisierte Studie. [Felbinac gel for treatment of localized extra-articular rheumatic diseases - a multicenter, placebo controlled, randomized study]. Z Rheumatol 1991, 50:109-113.
18. Brühlmann P, Michel BA: Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin Exp Rheumatol 2003, 21:193-198.
19. Dreiser RL, Tisne-Camus M: DHEP plasters as a topical treatment of knee osteoarthritis - a double-blind placebo-controlled study. Drugs Exp Clin Res 1993, 19:117-123.
20. Fotiades P, Bach GL: Wirkung einer flufenaminsaurehaltigen Salbe bei verschiedenen rheumatischen Erkrankungen. [The effect of a flufenamic acid containing ointment in various rheumatic diseases. A double blind study]. Fortschr Med 1976, 94:1036-1038.
21. Galeazzi M, Marcolongo R: A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases. Drugs Exp Clin Res 1993, 19:107-115.
22. Ginsberg F, Famaey JP: Double-blind, randomized crossover study of the percutaneous efficacy and tolerability of a topical indomethacin spray versus placebo in the treatment of tendinitis. J Int Med Res 1991, 19:131-136.
23. Grace D, Rogers J, Skeith K, Anderson K: Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee. J Rheumatol 1999, 26:2659-2663.
24. Gui L, Pellacci F, Ghirardini G: Impiego dell'ibuprofen crema in pazienti ambulatoriali di interesse ortopedico. Confronte in doppia cecità con placebo. [Use of ibuprofen cream in ambulatory orthopedic patients. Double blind comparison with placebo]. Clin Ter 1982, 101:363-369.
25. Hohmeister K: Die Behandlung von weichteilrheumatischen Erkrankungen mit Mobilisin Gel. Resultate einer Doppel-blind-Studie. [Treatment of rheumatic diseases of soft tissues with Mobilisin Gel. Results of a double blind study]. Fortschr Med 1983, 101:1586-1588.
26. Link R, Balint G, Pavlik G, Otto J, Krause W: Topische Behandlung von Weichteil-rheumatismus und Sportverletzungen. Wirksamkeit und Verträglichkeit eines neuen Ketoprofengels. [Topical treatment of soft tissue rheumatism and athletic injuries. Effectiveness and tolerance of a new ketoprofen gel]. Fortschr Med 1996, 114:311-314.
27. Mattara L, Trotta F, Biasi D, Cervetti R: Evaluation of the efficacy and tolerability of a new locally acting preparation of flurbiprofen in scapulohumeral periarthritis. Eur J Rheumatol Inflamm 1994, 4:15-20.
28. Poul J, West J, Buchanan N, Grahame R: Local action transcutaneous flurbipofen in the treatment of soft tissue rheumatism. Br J Rheumatol 1993, 32:1000-1003.
29. Rose W, Manz G, Lemmel EM: Behandlung der aktivierten gonarthrose mit topisch appliziertem piroxicam-gel. [Topical application of Piroxicam-gel in the treatment of activated gonarthrosis]. Munch Med Wschr 1991, 133:562-566.
30. Roth SH: A controlled clinical investigation of 3% diclofenac/2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis. Int J Tissue React 1995, 4:129-132.
31. Rovensky J, Micekova D, Gubzova Z, Fimmers R, Lenhard G, Vogtle-Junkert U, Schreyger F: Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream. Drugs Exp Clin Res 2001, 27:209-221.
32. Balthazar-Letawe D: Voltaren Emulgel en pratique rhumatologique. Essai comparatif avec Indocid gel. [Voltaren Emugel in clinical rheumatology. Comparative trial with lndocid gel]. Acta Belg Med Phys 1987, 10:109-110.
33. Burgos A, Busquier MP, Reino JG, Ferreiro JL, Navarro F, Valverde J, Moreno E: Double-blind, double-dummy comparative study of local action transcutaneous flurbiprofen (flurbiprofen LAT) versus piketoprofen cream in the treatment of extra-articular rheumatism. Clin Drug Invest 2001, 21:95-102.
34. Dickson DJ: A double-blind evaluation of topical piroxicam gel with oral ibuprofen in osteoarthritis of the knee. Curr Ther Res 1991, 49:199-207.
35. Geller O: Vergleich eines Salizylat/Heparin-Gels mit einem Mono-substanzpräparat. Ergebnisse einer Doppelblind-cross-over-Studie. [Comparison of a salicylate heparin gel with a monosubstance preparation. Results of a double blind cross over study]. Munch Med Wochenschr 1980, 122:1231-1232.
36. van Haselen RA, Fisher PA: A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee. Rheumatology 2000, 39:714-719.
37. Vitali G: Sperimentazione clinica controllata sull'impiego topico dell'acido 2-(3-benzoil-fenil) proprionico a tre diverse concentrazioni. [Controlled clinical experiment with the topical use of 2-(3-benzoyl-phenyl) propionic acid at 3 different concentrations]. Clin Ter 1980, 94:257-273.
38. Zacher J, Burger KJ, Farber L, Grave M, Abberger H, Bertsch K: Topical diclofenac versus oral ibuprofen: A double blind, randomized clinical trial to demonstrate efficacy and tolerability in patients with activated osteoarthritis of the finger joints (Heberden and/or Bouchard arthritis). Aktuelle Rheumatologie 2001, 26:7-14.
39. McCleane G: The addition of piroxicam to topically applied glyceryl trinitrate enhances its analgesic effect in musculoskeletal pain: A randomised, double-blind, placebo-controlled study. Pain Clinic 2000, 12:1 13-116.
40. Ottillinger B, Gomor B, Michel BA, Pavelka K, Beck W, Elsasser U: Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 2001, 9:273-280.
41. Sandelin J, Harilainen A, Crone H, Hamberg P, Forsskahl B, Tamelander G: Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol 1997, 26:287-292.
42. Terrin N, Schmid CH, Lau J, Olkin I: Adjusting for publication bias in the presence of heterogeneity. Stat Med 2003, 22:2113-2126.
43. MacLean CH, Morton SC, Ofman JJ, Roth EA, Shekelle PG: How useful are unpublished data from the Food and Drug Administration in meta-analysis? J Clin Epidemiol 2003, 56:44-51.
44. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J: How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 2003, 7:1-76.
45. Burdett S, Stewart LA, Tierney JF: Publication bias and meta-analyses: a practical example. Int J Technol Assess Health Care 2003, 19:129-134.
46. Kalso E, Moore RA: Five easy pieces on evidence-based medicine (2). Eur J Pain 2000, 4:321-324.
47. Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, MacDonald TM: Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 1995, 311:22-26.
48. Evans JM, McGregor E, McMahon AD, McGilchrist MM, Jones MC, White G, McDevitt DG, MacDonald TM: Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM 1995, 88:551-557.
49. Mason L, Moore RA, Edwards JE, McQuay HJ, Derry S, Wiffen PJ: Systematic review of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ 2004, 238:995-998.
50. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ: Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004, 238:991-994.
51. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ: Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 2004, 5:10.